These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7339646)

  • 41. Regional distribution and production rate of 3-methoxy-4-hydroxyphenylethyleneglycol sulphate (MHPG-SO4) in rat brain.
    Kohno Y; Tanaka M; Nakagawa R; Toshima N; Nagasaki N
    J Neurochem; 1981 Jan; 36(1):286-9. PubMed ID: 7463053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of anesthetic doses of hydroxybutyrate on subcortical concentrations of homovanillic acid.
    Roth RH
    Eur J Pharmacol; 1971 Jun; 15(1):52-9. PubMed ID: 5161341
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of acute and chronic treatment with tricyclic antidepressants on 3-methoxy-4-hydroxyphenylethyleneglycol sulfate (MHPG-SO4) contents in various regions of rat brain.
    Miyauchi T; Kitada Y; Satoh S
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(2):137-42. PubMed ID: 7202235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased brain norepinephrine metabolism correlated with analgesia produced by the periaqueductal gray injection of opiates.
    Reigle TG
    Brain Res; 1985 Jul; 338(1):155-9. PubMed ID: 4027585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increase of noradrenaline metabolism following electrical stimulation of the Locus coeruleus in the rat.
    Walter DS; Eccleston D
    J Neurochem; 1973 Aug; 21(2):281-9. PubMed ID: 4724319
    [No Abstract]   [Full Text] [Related]  

  • 46. In vivo measurement of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: effects of various drugs affecting noradrenaline metabolism.
    Itoh Y; Oishi R; Nishibori M; Saeki K
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1090-7. PubMed ID: 2262894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of noradrenergic neuronal activity on 3,4-dihydroxyphenylethylene glycol (DHPG) levels. Quantitation by high performance liquid chromatography.
    Jackman G; Snell J; Skews H; Bobik A
    Life Sci; 1982 Aug; 31(9):923-9. PubMed ID: 7176821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accumulation of 3-methoxy-4-hydroxyphenylglycol-sulfate in rabbit cerebrospinal fluid following probenecid.
    Extein I; Korf J; Roth RH; Bowers MB
    Brain Res; 1973 May; 54():403-7. PubMed ID: 4709155
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of intracerebroventricularly administered neostigmine on sympathetic neural activities of peripheral tissues in rats.
    Gotoh M; Smythe GA
    Brain Res; 1991 May; 548(1-2):326-8. PubMed ID: 1868343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain cortical tissue levels of noradrenaline and its glycol metabolites: effects of ischemia and postischemic administration of idazoxan.
    Gustafson I; Lidén A; Wieloch T
    Exp Brain Res; 1992; 90(3):551-6. PubMed ID: 1358670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuronal metabolism of catecholamines: plasma DHPG, DOMA and DOPAC.
    Dong WX; Schneider J; Lacolley P; Brisac AM; Safar M; Cuche JL
    J Auton Nerv Syst; 1993; 44(2-3):109-17. PubMed ID: 8227950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential changes in noradrenaline turnover in specific regions of rat brain produced by controllable and uncontrollable shocks.
    Tsuda A; Tanaka M
    Behav Neurosci; 1985 Oct; 99(5):802-17. PubMed ID: 3843302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine.
    Kawamura M; Kopin IJ; Kador PF; Sato S; Tjurmina O; Eisenhofer G
    J Auton Nerv Syst; 1997 Oct; 66(3):145-8. PubMed ID: 9406118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo measurement of neuronal uptake of norepinephrine in the human heart.
    Goldstein DS; Brush JE; Eisenhofer G; Stull R; Esler M
    Circulation; 1988 Jul; 78(1):41-8. PubMed ID: 3383409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A study of norepinephrine metabolism in rat brain using a double label technique.
    Brown FC; Zawad JS
    Biochem Pharmacol; 1977 Jul; 26(13):1251-4. PubMed ID: 880270
    [No Abstract]   [Full Text] [Related]  

  • 57. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.
    Goldstein DS; Eisenhofer G; Stull R; Folio CJ; Keiser HR; Kopin IJ
    J Clin Invest; 1988 Jan; 81(1):213-20. PubMed ID: 3335637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential modification by opioid agents of acutely enhanced noradrenaline release in discrete brain regions.
    Kohno Y; Tanaka M; Hoaki Y; Ida Y; Nagasaki N
    Eur J Pharmacol; 1983 Sep; 92(3-4):265-8. PubMed ID: 6313396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypothalamic monoamine control of stress-induced adrenocorticotropin release in the rat.
    Smythe GA; Bradshaw JE; Vining RF
    Endocrinology; 1983 Sep; 113(3):1062-71. PubMed ID: 6307661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A study of the formation and metabolic disposition of 3,4 dihydroxyphenylethyleneglycol in whole rat brain.
    Gale SW; Maas JW
    J Neural Transm; 1977; 41(1):59-72. PubMed ID: 915500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.